FDA Approves Personalized Brain Stimulation for PTSD Treatment
The FDA has cleared a new personalized brain stimulation treatment for Post-Traumatic Stress Disorder (PTSD). This non-medication alternative uses brain mapping and magnetic stimulation to target abnormal brain activity. Clinical trials demonstrated a 52% reduction in symptoms and a 68% remission rate, offering a promising new option for patients.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai